PNGAF (The Precision Peptide Co) Total Long-Term Assets: $0.00 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PNGAF The Precision Peptide Co Inc PNGAF
22 GF Score
Price $0.34
! 5 Warning Signs
View Full Analysis

What is The Precision Peptide Co Total Long-Term Assets?

The Precision Peptide Co PNGAF -1.54% 22 Total Long-Term Assets is $0.00 Mil as of Apr. 2026. GuruFocus rates PNGAF with a GF Score™ of 22/100. The stock has 5 warning signs investors should review.

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. The Precision Peptide Co's Total Long-Term Assets for the quarter that ended in Apr. 2026 was $0.00 Mil.

The Precision Peptide Co Total Long-Term Assets Related Terms

The Precision Peptide Co Total Long-Term Assets Historical Data

* Premium members only.

The historical data trend for The Precision Peptide Co's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Precision Peptide Co Total Long-Term Assets Chart

The Precision Peptide Co Annual Data
Trend Oct21 Oct22 Oct23 Oct24 Oct25
Total Long-Term Assets
0.05 0.02 0.01 0.00 0.00

The Precision Peptide Co Quarterly Data
Jul21 Oct21 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.39 1.65 0.00 0.00 0.00
PNGAF
22GF Score
The Precision Peptide Co Inc PNGAF
Total Long-Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Precision Peptide Co Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Frequently Asked Questions Learn more about Total Long-Term Assets →
What does a Total Long-Term Assets of $0.00 Mil mean?
The Precision Peptide Co (PNGAF) has a Total Long-Term Assets of $0.00 Mil as of Apr. 2026. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on The Precision Peptide Co and its competitors.
Is The Precision Peptide Co's Total Long-Term Assets too high?
The Precision Peptide Co's current Total Long-Term Assets is $0.00 Mil. Overall, The Precision Peptide Co has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does The Precision Peptide Co's Total Long-Term Assets compare to KHC and GIS?
The Precision Peptide Co's Total Long-Term Assets of $0.00 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Assets for a Consumer Packaged Goods company?
A good Total Long-Term Assets depends on the Consumer Packaged Goods industry context. However, Total Long-Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Assets mean?
A high Total Long-Term Assets can signal that a stock is expensive relative to its fundamentals. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on The Precision Peptide Co and its competitors. The Precision Peptide Co's current Total Long-Term Assets is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Precision Peptide Co stock overvalued right now?
The Precision Peptide Co (PNGAF) has a current Total Long-Term Assets of $0.00 Mil. The current Total Long-Term Assets is $0.00 Mil. The Precision Peptide Co's overall GF Score™ is 22/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Assets calculated?
Total Long-Term Assets is calculated from a company's financial statements. For The Precision Peptide Co (PNGAF), the current Total Long-Term Assets is $0.00 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Precision Peptide Co Business Description

Other Exchanges XU0:GermanyBPC:Canada
Address 130th Street, Suite 8035, Surrey, BC, CAN, V3W 0H7
The Precision Peptide Co Inc is a food manufacturer and distributor of nutritional supplements, functional snacks, natural foods, peptides, and natural personal care products. The company offers end-to-end services from formulation and ingredient sourcing to final packaging and fulfillment. The Company has two reportable operating segments: the manufacturing and distribution of food products in Canada and the sale and delivery of its peptide products in the United States.
22GF Score

Get the complete analysis for PNGAF

Total Long-Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.34
Price